Bharat Biotech’s COVID-19 vaccine COVAXIN phase 1 clinical trial findings reveal no serious adverse effects: Interim report
New Delhi: The phase 1 clinical trial findings of Bharat Biotech’s COVID-19 vaccine ‘COVAXIN’ has revealed no serious adverse effects, said the interim report. Around...